Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

ZD1839 can cause skin issues like acne and hair changes.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Skin cells can naturally limit the growth of cancerous changes by balancing cell renewal and differentiation.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The FDA approved a new Pfizer drug for hair loss in teens.